Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 7, 2025 | Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement | Funding expected to support first clinical trial of APTN-101 for the treatment of glioblastoma CHARLOTTE, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing... |
Reviews 0
FAQ about Lucius Partners
What has the press written about Lucius Partners?
Parsers VC has collected 2 articles mentioning Lucius Partners, among them “Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement” (Apr 7, 2025).
Is Lucius Partners still active?
Lucius Partners is probably closed: its latest activity on Parsers VC dates from Jul 22, 2025.